Effects of Delays on Heart Attack Outcomes

Impact of Pre-Hospital and Hospital Delays on Myocardial Infarction Outcomes

Recruiting Observational Study
Myocardial Infarction (MI)
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
200 (estimated)
Sponsor
Al-Nahrain University · Other
Who this trial is looking for

This trial is looking for people who have had a heart attack and are treated at Al-Kadhimiya Teaching Hospital. Participants will have their treatment times and health outcomes tracked to see how delays affect recovery.

Are You a Good Fit for This Trial?

You may be able to join if

  • I can give consent or my representative can give consent for me.
  • I am receiving reperfusion therapy like thrombolysis or PCI.
  • I was admitted to the hospital within 12 hours of my symptoms starting.

You may not be able to join if

  • I have had a heart attack in the past.
  • I have serious health conditions like advanced cancer or kidney disease.
  • I was transferred to another hospital before receiving treatment.
  • I am pregnant or breastfeeding.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goal of this prospective observational study is to investigate the impact of pre-hospital and hospital delays on the outcomes of myocardial infarction (MI) patients admitted to Al-Kadhimiya Teaching Hospital, Baghdad. The main questions it aims to answer are: How do pre-hospital delays (e.g., patient transport and first medical contact) affect clinical outcomes such as mortality, complicatio…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients who provide informed consent (or a legal representative provides consent if the patient is unable to do so). * Patients who undergo reperfusion therapy, such as thrombolysis or percutaneous coronary intervention (PCI). * Patients admitted to Al-Kadhimiya Teaching Hosp…
Contacts

Abdulillah R. Khamees

+9647838571013

allaabed987@ced.nahrainuniv.edu.iq

CONTACT